Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Associations of Patient Mood, Modulators of Quality of Life, and Pharmaceuticals with Amyotrophic Lateral Sclerosis Survival Duration.

Bond L, Bowen G, Mertens B, Denson K, Jordan K, Vidakovic B, Mitchell CS.

Behav Sci (Basel). 2020 Jan 10;10(1). pii: E33. doi: 10.3390/bs10010033.

2.

A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes.

Bond L, Ganguly P, Khamankar N, Mallet N, Bowen G, Green B, Mitchell CS.

Brain Sci. 2019 Sep 4;9(9). pii: E223. doi: 10.3390/brainsci9090223.

3.

SemNet: Using Local Features to Navigate the Biomedical Concept Graph.

Sedler AR, Mitchell CS.

Front Bioeng Biotechnol. 2019 Jul 3;7:156. doi: 10.3389/fbioe.2019.00156. eCollection 2019.

4.

Astrocyte-Mediated Neuromodulatory Regulation in Preclinical ALS: A Metadata Analysis.

Jordan K, Murphy J, Singh A, Mitchell CS.

Front Cell Neurosci. 2018 Dec 17;12:491. doi: 10.3389/fncel.2018.00491. eCollection 2018.

5.

Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols.

Khamankar N, Coan G, Weaver B, Mitchell CS.

Front Neurol. 2018 Jul 12;9:578. doi: 10.3389/fneur.2018.00578. eCollection 2018.

6.

Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction.

Pfohl SR, Kim RB, Coan GS, Mitchell CS.

Front Neuroinform. 2018 Jun 14;12:36. doi: 10.3389/fninf.2018.00036. eCollection 2018.

7.

A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.

Bond L, Bernhardt K, Madria P, Sorrentino K, Scelsi H, Mitchell CS.

Front Neurosci. 2018 Jan 24;12:10. doi: 10.3389/fnins.2018.00010. eCollection 2018.

8.

Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.

Huber CM, Yee C, May T, Dhanala A, Mitchell CS.

J Alzheimers Dis. 2018;61(1):265-281. doi: 10.3233/JAD-170490. Review.

9.

Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

Hollinger SK, Okosun IS, Mitchell CS.

Front Neurol. 2016 Mar 29;7:47. doi: 10.3389/fneur.2016.00047. eCollection 2016.

10.

Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.

Jeyachandran A, Mertens B, McKissick EA, Mitchell CS.

Front Cell Neurosci. 2015 Dec 1;9:462. doi: 10.3389/fncel.2015.00462. eCollection 2015.

12.

Undergraduate Biocuration: Developing Tomorrow's Researchers While Mining Today's Data.

Mitchell CS, Cates A, Kim RB, Hollinger SK.

J Undergrad Neurosci Educ. 2015 Oct 15;14(1):A56-65. eCollection 2015 Fall.

13.

Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.

Irvin CW, Kim RB, Mitchell CS.

Front Cell Neurosci. 2015 Jul 1;9:248. doi: 10.3389/fncel.2015.00248. eCollection 2015.

14.

An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies.

Coan G, Mitchell CS.

Neurodegener Dis. 2015;15(5):301-12. doi: 10.1159/000433581. Epub 2015 Jul 16.

15.

State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.

Kim RB, Irvin CW, Tilva KR, Mitchell CS.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):1-14. doi: 10.3109/21678421.2015.1047455. Epub 2015 May 22. Review.

16.

Antecedent Disease is Less Prevalent in Amyotrophic Lateral Sclerosis.

Mitchell CS, Hollinger SK, Goswami SD, Polak MA, Lee RH, Glass JD.

Neurodegener Dis. 2015;15(2):109-13. doi: 10.1159/000369812. Epub 2015 Feb 20.

17.

Axonal transport cargo motor count versus average transport velocity: is fast versus slow transport really single versus multiple motor transport?

Lee RH, Mitchell CS.

J Theor Biol. 2015 Apr 7;370:39-44. doi: 10.1016/j.jtbi.2015.01.010. Epub 2015 Jan 20.

18.

Systematic review of the relationship between amyloid-β levels and measures of transgenic mouse cognitive deficit in Alzheimer's disease.

Foley AM, Ammar ZM, Lee RH, Mitchell CS.

J Alzheimers Dis. 2015;44(3):787-95. doi: 10.3233/JAD-142208. Review.

19.

Revisiting the role of spike afterhyperpolarization and spike threshold in motoneuron current-frequency gain.

Lee RH, Mitchell CS.

J Neurophysiol. 2012 Jun;107(11):3071-7. doi: 10.1152/jn.01195.2011. Epub 2012 Mar 14.

20.

Cargo distributions differentiate pathological axonal transport impairments.

Mitchell CS, Lee RH.

J Theor Biol. 2012 May 7;300:277-91. doi: 10.1016/j.jtbi.2012.01.019. Epub 2012 Jan 25.

Supplemental Content

Loading ...
Support Center